IBT
International Biotechnology Trust’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.74M | Buy |
179,702
+28,702
| +19% | +$597K | 1.26% | 24 |
|
|
2023
Q2 | $3.62M | Sell |
151,000
-65,000
| -30% | -$1.56M | 1.1% | 29 |
|
|
2023
Q1 | $4.06M | Buy |
216,000
+116,000
| +116% | +$2.18M | 1.13% | 31 |
|
|
2022
Q4 | $1.59M | Buy |
+100,000
| New | +$1.59M | 0.49% | 40 |
|
|
2021
Q2 | – | Sell |
-59,514
| Closed | -$1.53M | – | 67 |
|
|
2021
Q1 | $1.53M | Sell |
59,514
-426,486
| -88% | -$11M | 0.41% | 38 |
|
|
2020
Q4 | $26M | Hold |
486,000
| – | – | 7.1% | 2 |
|
|
2020
Q3 | $20M | Buy |
486,000
+181,000
| +59% | +$7.47M | 6.47% | 4 |
|
|
2020
Q2 | $14.7M | Sell |
305,000
-32,000
| -9% | -$1.54M | 4.89% | 7 |
|
|
2020
Q1 | $14.2M | Buy |
337,000
+1,000
| +0.3% | +$42.2K | 6.49% | 5 |
|
|
2019
Q4 | $14.4M | Buy |
336,000
+268,000
| +394% | +$11.5M | 5.18% | 4 |
|
|
2019
Q3 | $2.45M | Buy |
68,000
+15,000
| +28% | +$540K | 1.13% | 21 |
|
|
2019
Q2 | $1.42M | Sell |
53,000
-216,000
| -80% | -$5.77M | 0.52% | 45 |
|
|
2019
Q1 | $7.22M | Sell |
269,000
-13,065
| -5% | -$351K | 2.67% | 13 |
|
|
2018
Q4 | $3.58M | Buy |
282,065
+217,065
| +334% | +$2.75M | 2.22% | 17 |
|
|
2018
Q3 | $1.04M | Buy |
+65,000
| New | +$1.04M | 0.49% | 43 |
|
|
2018
Q2 | – | Sell |
-42,773
| Closed | -$961K | – | 55 |
|
|
2018
Q1 | $961K | Sell |
42,773
-291,000
| -87% | -$6.54M | 0.37% | 53 |
|
|
2017
Q4 | $10M | Buy |
333,773
+93,000
| +39% | +$2.8M | 3.54% | 8 |
|
|
2017
Q3 | $9.07M | Buy |
240,773
+103,000
| +75% | +$3.88M | 3.53% | 8 |
|
|
2017
Q2 | $3.84M | Buy |
137,773
+88,122
| +177% | +$2.46M | 1.46% | 22 |
|
|
2017
Q1 | $1.71M | Sell |
49,651
-807
| -2% | -$27.7K | 0.65% | 35 |
|
|
2016
Q4 | $1.46M | Buy |
+50,458
| New | +$1.46M | 0.66% | 30 |
|